A transient inhibition of PFKFB3 in endothelial cells using 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) induced tumor vessel normalization, impaired metastasis, and improved chemotherapy [107,108]. The gene discussed is PFKFB3; the disease is neoplasm.